Ketoconazole gel

Alternative Names: Xolegel; Xolegel CorePak; Xolegel Duo

Latest Information Update: 24 Mar 2018

Price : ^*

* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

Originator Johnson & Johnson
Developer Barrier Therapeutics Inc; Stiefel Laboratories
Class Antifungals; Azoles; Piperazines; Small molecules
Mechanism of Action 14-alpha demethylase inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Marketed Seborrhoeic dermatitis

Most Recent Events

17 Apr 2016 Biomarkers information updated
22 Jul 2009 Stiefel Laboratories has been acquired by GlaxoSmithKline
08 Aug 2008 Discontinued - Phase-III for Seborrhoeic dermatitis in Belgium (Topical)

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login with a username/password associated to an account with a valid subscription
Contact your organization’s admin about adding this content to your AdisInsight subscription
Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.